STOCK TITAN
  1. Home
  2. Sec-filings
  3. EFX
  4. [Form 4] Equifax, Incorporated Insider Trading Activity

EFX Insider Sale: John Gamble Jr. Disposes 3,000 Shares via 10b5-1 Plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Equifax insider sale by EVP/CFO/COO. John W. Gamble Jr., Equifax (EFX) executive, sold 3,000 shares of Common Stock on 08/18/2025 at $247.35 per share under a pre-established Rule 10b5-1 trading plan adopted 05/14/2025. After the sale he beneficially owns 62,202 shares, which figure includes accrued dividend equivalent units reinvested into restricted stock units through the company’s last dividend payment date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/20/2025.

Positive

  • Sale executed under a Rule 10b5-1 trading plan, indicating the transaction was pre-planned
  • Clear disclosure of post-transaction beneficial ownership (62,202 shares) including reinvested dividend equivalents

Negative

  • Insider disposed of 3,000 shares, reducing direct holdings by that amount
  • Form 4 does not state proceeds or purpose of sale, limiting context for investors

Insights

TL;DR: Routine, pre-planned insider sale under a 10b5-1 plan; not an unplanned red flag.

The filing documents a planned disposition executed under a Rule 10b5-1 plan adopted on 05/14/2025, which provides the reporting person an affirmative defense against insider trading claims for transactions made pursuant to the plan. The disclosure lists the executive role (EVP, CFO & COO) and shows retained beneficial ownership of 62,202 shares including reinvested dividend equivalents. From a governance perspective, use of a 10b5-1 plan signals structured selling rather than opportunistic trading, but investors may note the timing and size relative to overall holdings.

TL;DR: Small, disclosed sale; limited market or valuation impact based on disclosed amounts.

The transaction is a sale of 3,000 shares at $247.35 each on 08/18/2025. Proceeds implied by the reported price are calculable from the disclosed quantity and price, but the filing does not provide proceeds or tax/vesting details. The report confirms continuing beneficial ownership of 62,202 shares. This is a straightforward insider sale disclosure without accompanying commentary on company performance or material events.

Insider GAMBLE JOHN W JR
Role EVP, CFO & COO
Sold 3,000 shs ($742K)
Type Security Shares Price Value
Sale Common Stock 3,000 $247.35 $742K
Holdings After Transaction: Common Stock — 62,202 shares (Direct)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GAMBLE JOHN W JR
(Last) (First) (Middle)
1550 PEACHTREE STREET, N.W.
(Street)
ATLANTA GA 30309
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CFO & COO
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 S(1) 3,000 D $247.35 62,202(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.
2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
/s/Lisa Stockard as Attorney-in-Fact 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Equifax (EFX) insider John W. Gamble Jr. report on Form 4?

The Form 4 reports that John W. Gamble Jr. sold 3,000 shares of Equifax common stock on 08/18/2025 at $247.35 per share.

Was the sale by the Equifax executive part of a Rule 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 05/14/2025.

How many Equifax shares does the reporting person own after the sale?

The filing shows beneficial ownership of 62,202 shares following the reported transaction, which includes accrued dividend equivalent units reinvested into restricted stock units.

What price was reported for the sale of EFX shares?

The reported sale price was $247.35 per share for the 3,000 shares sold.

Who signed the Form 4 filing for the Equifax reporting person?

The Form 4 was signed on behalf of the reporting person by Lisa Stockard as Attorney-in-Fact on 08/20/2025.